Suppr超能文献

帕金森病患者丘脑底核脑深部电刺激术后出现症状性、非感染性、非出血性水肿。

Symptomatic, non-infectious, non-hemorrhagic edema after subthalamic nucleus deep brain stimulation surgery for Parkinson's disease.

机构信息

Department of Neurosurgery, University of Kansas Medical Center, Kansas City, KS, USA.

Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.

出版信息

J Neurol Sci. 2017 Dec 15;383:42-46. doi: 10.1016/j.jns.2017.10.003. Epub 2017 Oct 12.

Abstract

OBJECT

We review our experience with Parkinson's disease (PD) patients who underwent subthalamic nucleus (STN) deep brain stimulation (DBS) and then developed noninfectious, non-hemorrhagic, delayed, symptomatic brain edema associated with a DBS lead.

METHODS

All PD patients who underwent STN DBS lead implantation from 2007 to 2015 were included. The same neurosurgeon performed all surgeries, typically in staged fashion, utilizing single pass microelectrode recordings (MER) within a stereotactic frame. A brain CT was obtained in recovery and subsequently if indicated.

RESULTS

There were 189 patients who underwent 363 STN lead implantations among which 35 (9.6%) represent re-implantations of removed leads in 28 (14.8%) patients. Among the 363 STN leads implanted, there were 12 (3.3%) cases of delayed symptomatic edema associated with a DBS lead involving 10 (5.3%) of the patients studied. Of the 328 leads representing first-time operations, there were 9 (2.1%) cases of delayed symptomatic edema in 7 (3.7%) patients, one of whom (14.3%) presented with seizures. For lead re-implantations, there were 3 (8.6%) cases of the brain edema in 3 (10.7%) patients; all presenting with seizures. For the 35 re-implantations, the trajectory to target was the same or very similar via the same burr hole as prior surgery in 17 (48.6%); 3 (17.6%) of whom developed edema. There was no case of brain edema in the 18 re-operated cases using a different burr opening. Edema patients were treated with a course of anticonvulsant medication and dexamethasone. Lead-associated edema resolved over generally a 4 to 6-week course.

CONCLUSIONS

Noninfectious, non-hemorrhagic, delayed, symptomatic brain edema occurs in approximately 3% of implanted leads and is more common in re-implantations (9%) compared to new implantations (2%). In re-implantations, the edema is more common when the same trajectory is used (18%) compared to a new trajectory (0%). The edema generally occurs 3 to 8 days after implantation, although immediate post-op CT is normal and seizures are a common presenting feature.

摘要

目的

我们回顾了因植入的深部脑刺激(DBS)导联而发生非感染性、非出血性、延迟性、症状性脑水肿的帕金森病(PD)患者的经验,这些患者与 DBS 导联有关。

方法

纳入 2007 年至 2015 年间接受 STN-DBS 导联植入的所有 PD 患者。同一位神经外科医生进行了所有手术,通常采用单次微电极记录(MER)在立体定向框架内进行。术后患者在恢复期间和需要时会进行脑部 CT 检查。

结果

189 例患者共进行了 363 次 STN 导联植入,其中 35 例(9.6%)为 28 例患者(14.8%)移除的导联重新植入。在植入的 363 个 STN 导联中,有 12 个(3.3%)导联出现与 DBS 导联相关的延迟性症状性水肿,涉及 10 名患者(5.3%)。在 328 个首次手术的导联中,有 7 名患者(3.7%)出现 9 例(2.1%)延迟性症状性水肿,其中 1 例(14.3%)出现癫痫发作。对于导联重新植入,3 名患者(8.6%)中有 3 例(10.7%)发生脑水肿,均出现癫痫发作。在 35 例重新植入的患者中,有 17 例(48.6%)的目标靶点轨迹与之前的手术相同或非常相似,通过相同的骨孔;其中 3 例(17.6%)发生水肿。在使用不同骨孔的 18 例再次手术中,没有发生脑水肿的病例。水肿患者接受了抗惊厥药物和地塞米松治疗。与导联相关的水肿通常在 4 至 6 周的疗程中消退。

结论

植入导联中约有 3%发生非感染性、非出血性、延迟性、症状性脑水肿,在重新植入(9%)中比新植入(2%)更为常见。在重新植入中,当使用相同的轨迹时(18%)比新轨迹(0%)更常见。水肿通常发生在植入后 3 至 8 天,尽管术后即刻 CT 正常,癫痫发作是常见的首发症状。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验